KAISER LAB CONFERENCE RM

The Epidemiology of Burkitt Lymphoma in East-African Children and Minors (EMBLEM) is a research initiative sponsored by the Intramural Research program of the National Cancer Institute, focused on investigating the infections, immunological, and genetic risk factors associated with Burkitt lymphoma in malaria-endemic regions of Uganda, Tanzania, and Kenya. Through comprehensive case control studies, EMBLEM aims to uncover the complexities of Burkitt lymphoma and identify potential therapeutic targets and biomarkers. EMBLEM employs a multidisciplinary approach, utilizing demographic data, questionnaire responses, serological tests, and genetic analysis to explore the risk factors for Burkitt lymphoma in children aged 0-15 years. Furthermore, the project encourages collaboration by sharing unique biological samples and field experience, thereby enhancing research opportunities in rural Africa. Generated from the website

The NIH Office of Disease Prevention, based in Rockville, MD, is dedicated to advancing public health through research and evidence-based strategies. With a focus on disease prevention and health promotion, the office collaborates with various stakeholders to develop and implement initiatives that improve population health outcomes. Generated from their business information